# OnCo record ptx-912 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ptx-912/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ptx-912" ;
  schema:name "PTX-912"@en ;
  schema:description "PTX-912 is an experimental immune-stimulating protein from Proviva Therapeutics, in phase 1 trials for advanced solid tumours."@en ;
  schema:url <https://onco.cc/drugs/ptx-912/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://news.pedaily.cn/202403/530729.shtml>, <https://clinicaltrials.gov/study/NCT06190886> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Fusion protein (interleukin-2 prodrug)" ;
  onco:companies <https://onco.cc/companies/proviva-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct06190886/> .